SYNE1 and hepatocellular carcinoma: A report published by Shaglof et al. had demonstrated that one rarely studied isoform derived from alternatively spliced variants of SYNE1/Nesprin-1, named X6, was elevated in HCC-bearing rats, which might play a role in hepatocarcinogenesis and cancer progression [39].